Article
VISTAKON vistas: The VISTAKON unit of Johnson & Johnson may spend more than $30 million to build a new research and development center in Jacksonville, FL. The center, to be completed in September 2003, will develop new VISTAKON products.
Study estimates glaucoma and vision-affecting glaucoma prevalence by demographic factors
Week in Review - October 5, 2024
The top 10 takeaways from AAO 2024
Innovation Series: AI’s impact on managing ocular surface disease with Peter J. McDonnell, MD, and Laura M. Periman, MD
Ocuphire completes acquisition of Opus Genetics
New case study seeks to enhance perspectives in international ophthalmology partnerships